title: Bullous fixed drug eruption in a patient with metastatic renal cell carcinoma induced by iodinated contrast during pazopanib treatment.
authors.affiliation: Department of Internal Medicine.
authors.forename: Cynthia
authors.initials: C
authors.lastname: Epskamp
authors.affiliation: Department of Dermatology.
authors.forename: Dyon G C T M
authors.initials: DG
authors.lastname: Snels
authors.affiliation: Department of Radiology; Sint Franciscus Gasthuis, Postbus 10900 3004BA, Rotterdam, The Netherlands.
authors.forename: Glenn L
authors.initials: GL
authors.lastname: Yo
authors.affiliation: Department of Internal Medicine.
authors.forename: Hanneke J M
authors.initials: HJ
authors.lastname: Zuetenhorst
authors.affiliation: Department of Internal Medicine.
authors.forename: Paul
authors.initials: P
authors.lastname: Hamberg
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001768:Blister / Q000139:chemically induced*; D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging / Q000556:secondary / Q000628:therapy*; D003287:Contrast Media / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D006229:Hand Dermatoses / Q000139:chemically induced*; D006801:Humans; D007191:Indazoles; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D014283:Triiodobenzoic Acids / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D003287:Contrast Media; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; D014283:Triiodobenzoic Acids; C516667:pazopanib; C044834:iodixanol